Tanja Braakman

Statistics

Publications

Citations

8.3K

H-Index

Active since

1997

Affiliations

Amsterdam UMC Location University of Amsterdam(Current)

Cedars-Sinai Medical Center

University of Chicago

Mount Sinai Medical Center

Universitair Ziekenhuis Leuven

Tanja Braakman is an author at Amsterdam UMC Location University of Amsterdam specializing in inflammation, inflammatory bowel disease, and inflammatory bowel disease therapy.

Publications per year

1997–2004

Publications

A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease

Stephan R. Targan, Stephen B. Hanauer, Sander J. H. van Deventer et al. · New England Journal of Medicine · 1997 · 3.2K citations · Full text

Pharmacy, Immunology, Inflammation +12

Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease

Daniel H. Present, Paul Rutgeerts, Stephan Targan et al. · New England Journal of Medicine · 1999 · 2.7K citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +14

Efficacy and safety of retreatment with anti–tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease

Paul Rutgeerts, Geert D’Haens, Stephan R. Targan et al. · Gastroenterology · 1999 · 1.1K citations · Full text

Life Sciences, Immunology, Pharmacotherapy +10

Endoscopic and histological healing with infliximab anti–tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial

Geert D’Haens, Sander van Deventer, Ruud van Hogezand et al. · Gastroenterology · 1999 · 756 citations · Full text

Veterinary Medicine, Immunology, Internal Medicine +14

Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human α-L-iduronidase (laronidase)

J. E. Wraith, L. Clarke, Michael Beck et al. · The Journal of Pediatrics · 2004 · 546 citations

Life Sciences, Biochemistry, Enzymology +7

1–5 of 5